The Omaha Marriott became a hub of conversation last weekend during the Berkshire Hathaway annual meeting, thanks to a 24-inch tall, bronze bust sculpture of the late Charlie Munger. Munger, who passed away in November at the age of 99, was a renowned investment icon and the longtime partner of Warren Buffett. The sculpture, placed
0 Comments
The restaurant industry has been experiencing a slowdown in sales and traffic, with companies like McDonald’s and Starbucks facing challenges due to customers seeking deals and good value. However, fast-casual chains like Chipotle Mexican Grill, Wingstop, and Sweetgreen have managed to buck this trend. These chains have reported strong sales, with high-income consumers playing a
0 Comments
Michael Saylor, the founder and chairman of MicroStrategy, is a well-known advocate for Bitcoin. He has been leading the charge in promoting the world’s most popular cryptocurrency as the ultimate investment option. Saylor has been vocal about his belief that Bitcoin is the only cryptocurrency worth considering as a long-term investment. In a recent statement,
0 Comments
Goldman Sachs recently highlighted several tech stocks that are currently undervalued and present good buying opportunities after the latest earnings reports in the market. According to information from FactSet, a significant percentage of S & P 500 companies have reported earnings that beat estimates, with the information technology sector showing notable growth. This indicates a
0 Comments
Real estate stocks have recently been flagged as oversold, providing a potential opportunity for investors looking to capitalize on this dip. According to BMO’s chief investment strategist Brian Belski, the real estate sector has been underperforming relative to the S&P 500, with a year-to-date decline of 6%. Belski suggests that this abnormal underperformance may signal
0 Comments
The Virginia General Assembly has seen its fair share of battles and negotiations regarding the state’s budget. From clashes over environmental issues to school funding, the process has been anything but smooth. The saga that unfolded between the state’s Republican governor and the Democratically controlled legislature has kept the budget in a constant state of
0 Comments
Moderna, a well-known biotech company, has recently announced that the approval of its vaccine for respiratory syncytial virus (RSV) has been delayed by the Food and Drug Administration (FDA) until the end of May. This delay has been attributed to “administrative constraints” at the agency, causing uncertainty among investors and stakeholders. The FDA’s decision to
0 Comments